Company Filing History:
Years Active: 2017
Title: Innovations by Sebastein Robert Gaston Thomas
Introduction
Sebastein Robert Gaston Thomas is a notable inventor based in Val de Reuil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. His work is characterized by a focus on novel chemical derivatives that have the potential to treat bacterial infections.
Latest Patents
Sebastein holds a patent for "Antibacterial quinoline derivatives." This invention relates to novel substituted quinoline derivatives, which are described by the general Formula (Ia) or Formula (Ib). The patent includes any stereochemically isomeric form, a pharmaceutically acceptable salt, an N-oxide form, or a solvate of the compounds. The claimed compounds are particularly useful for treating bacterial infections. Additionally, the patent covers a composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of the claimed compounds. It also outlines the use of these compounds or compositions for the manufacture of a medicament aimed at treating bacterial infections, along with a process for preparing the claimed compounds.
Career Highlights
Sebastein is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions for healthcare challenges, particularly in the area of infectious diseases.
Collaborations
Sebastein has collaborated with notable colleagues, including Jerome Emile Georges Guillemont and Magali Madeleine Simone Motte. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Sebastein Robert Gaston Thomas is a distinguished inventor whose work in antibacterial quinoline derivatives showcases his commitment to addressing critical health issues. His contributions to the field of pharmaceuticals are significant and reflect the importance of innovation in medical science.